相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Sameer Jauhar et al.
MOLECULAR PSYCHIATRY (2019)
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia
Meredith A. Reid et al.
SCHIZOPHRENIA BULLETIN (2019)
Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study
Naren Rao et al.
SCHIZOPHRENIA BULLETIN (2019)
Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study
Robert A. McCutcheon et al.
BIOLOGICAL PSYCHIATRY (2019)
Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-D-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors
Hualong Fu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro
Izabela Zakrocka et al.
NEUROTOXICITY RESEARCH (2019)
GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study
Tania Da Silva et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2019)
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Clifford M. Cassidy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
Toby Pillinger et al.
PSYCHOPHARMACOLOGY (2019)
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis Substance Use and Misuse
Alexandra Voce et al.
SUBSTANCE USE & MISUSE (2019)
Multiscale Neuroscience of Psychiatric Disorders
Martijn P. van den Heuvel et al.
BIOLOGICAL PSYCHIATRY (2019)
Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms
Mihai Avram et al.
BRAIN (2019)
D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Per Stenkrona et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Nonsocial and social cognition in schizophrenia: current evidence and future directions
Michael F. Green et al.
WORLD PSYCHIATRY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study
Enrico D'Ambrosio et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2019)
Migration, ethnicity and psychoses: evidence, models and future directions
Craig Morgan et al.
WORLD PSYCHIATRY (2019)
Neural correlates of cognitive deficits across developmental phases of schizophrenia
Sinead Kelly et al.
NEUROBIOLOGY OF DISEASE (2019)
Glutamate hypothesis in schizophrenia
Yota Uno et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Chronic psychosocial stressors are associated with alterations in salience processing and corticostriatal connectivity
Robert A. McCutcheon et al.
SCHIZOPHRENIA RESEARCH (2019)
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
Robert A. McCutcheon et al.
TRENDS IN NEUROSCIENCES (2019)
Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
Anna M. Wang et al.
JAMA PSYCHIATRY (2019)
The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data
Adam Al-Diwani et al.
LANCET PSYCHIATRY (2019)
Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia
Alice Petty et al.
NPJ SCHIZOPHRENIA (2019)
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M. Kokkinou et al.
MOLECULAR PSYCHIATRY (2018)
Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naive Schizophrenia
Huai-Hsuan Tseng et al.
SCHIZOPHRENIA BULLETIN (2018)
Glutamatergic Response to Heat Pain Stress in Schizophrenia
Joshua Chiappelli et al.
SCHIZOPHRENIA BULLETIN (2018)
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Robert McCutcheon et al.
SCHIZOPHRENIA BULLETIN (2018)
Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia
Mark Slifstein et al.
BIOLOGICAL PSYCHIATRY (2018)
Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects
Deepak Cyril D'Souza et al.
BIOLOGICAL PSYCHIATRY (2018)
The Predictive Coding Account of Psychosis
Philipp Sterzer et al.
BIOLOGICAL PSYCHIATRY (2018)
Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia
W. Gordon Frankle et al.
BIOLOGICAL PSYCHIATRY (2018)
Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis
Christin Schifani et al.
BRAIN (2018)
A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine
Clifford M. Cassidy et al.
CURRENT BIOLOGY (2018)
Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome
Esther D. A. van Duin et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [F-18]-DOPA PET study
Tarik Dahoun et al.
HUMAN MOLECULAR GENETICS (2018)
Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia
Luke A. Jelen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre H-1-MRS study (OPTiMiSE)
A. Egerton et al.
MOLECULAR PSYCHIATRY (2018)
Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention
J. A. Lieberman et al.
MOLECULAR PSYCHIATRY (2018)
Dorsal tegmental dopamine neurons gate associative learning of fear
Florian Groessl et al.
NATURE NEUROSCIENCE (2018)
Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans
Tara L. White et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations
P. R. A. Heckman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis
Claudia Vingerhoets et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2018)
What causes psychosis? An umbrella review of risk and protective factors
Joaquim Radua et al.
WORLD PSYCHIATRY (2018)
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders A Randomized Clinical Trial
Daniel C. Javitt et al.
JAMA PSYCHIATRY (2018)
THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders
Boris Guennewig et al.
TRANSLATIONAL PSYCHIATRY (2018)
The integrated landscape of causal genes and pathways in schizophrenia
Changguo Ma et al.
TRANSLATIONAL PSYCHIATRY (2018)
Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli
William Menegas et al.
NATURE NEUROSCIENCE (2018)
Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia
Wan-Ju Cheng et al.
SCHIZOPHRENIA RESEARCH (2018)
Dopaminergic basis for signaling belief updates, but not surprise, and the link to paranoia
Matthew M. Nour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Michael J. Gandal et al.
SCIENCE (2018)
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
Sameer Jauhar et al.
LANCET PSYCHIATRY (2018)
Decoupling of Brain Temperature and Glutamate in Recent Onset of Schizophrenia: A 7T Proton Magnetic Resonance Spectroscopy Study
Sotirios Posporelis et al.
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2018)
Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia
Manabu Kubota et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum
D. R. Roalf et al.
MOLECULAR PSYCHIATRY (2017)
Dynamic models of large-scale brain activity
Michael Breakspear
NATURE NEUROSCIENCE (2017)
Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study
Eric Artiges et al.
SCHIZOPHRENIA BULLETIN (2017)
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman et al.
SCHIZOPHRENIA BULLETIN (2017)
Metabotropic glutamate receptor 5 neuroimaging in schizophrenia
Funda Akkus et al.
SCHIZOPHRENIA RESEARCH (2017)
Pavlovian conditioning-induced hallucinations result from overweighting of perceptual priors
A. R. Powers et al.
SCIENCE (2017)
Opposite initialization to novel cues in dopamine signaling in ventral and posterior striatum in mice
William Menegas et al.
ELIFE (2017)
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Sameer Jauhar et al.
JAMA PSYCHIATRY (2017)
Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain
T. D. Purves-Tyson et al.
TRANSLATIONAL PSYCHIATRY (2017)
Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans
S. Jauhar et al.
TRANSLATIONAL PSYCHIATRY (2017)
Acute stress effects on GABA and glutamate levels in the prefrontal cortex: A 7T 1H magnetic resonance spectroscopy study
L. C. Houtepen et al.
NEUROIMAGE-CLINICAL (2017)
Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies
Alice Egerton et al.
FRONTIERS IN PSYCHIATRY (2017)
An Integrative Perspective on the Role of Dopamine in Schizophrenia
Tiago V. Maia et al.
BIOLOGICAL PSYCHIATRY (2017)
Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
Elias Mouchlianitis et al.
SCHIZOPHRENIA BULLETIN (2016)
Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes
Tune H. Pers et al.
HUMAN MOLECULAR GENETICS (2016)
Prefrontal cortex dopamine release measured in vivo with positron emission tomography: Implications for the stimulant paradigm
D. Hernaus et al.
NEUROIMAGE (2016)
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release
Daniel J. Foster et al.
NEURON (2016)
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
Marco Colizzi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users
Ni Fan et al.
PSYCHIATRY RESEARCH (2016)
Targeting glutamate to treat schizophrenia: lessons from recent clinical studies
Katherine Beck et al.
PSYCHOPHARMACOLOGY (2016)
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Alice Egerton et al.
SCHIZOPHRENIA RESEARCH (2016)
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A 1H MRS Study at 7 Tesla
Allison S. Brandt et al.
SCHIZOPHRENIA RESEARCH (2016)
Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study
Alexis C. Edwards et al.
SCHIZOPHRENIA RESEARCH (2016)
Dopamine D1 signaling organizes network dynamics underlying working memory
Joshua L. Roffman et al.
SCIENCE ADVANCES (2016)
Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study
Edith Liemburg et al.
SCIENTIFIC REPORTS (2016)
Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
Elias Mouchlianitis et al.
LANCET PSYCHIATRY (2016)
Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits
Talia N. Lerner et al.
CELL (2015)
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond
Darrick T. Balu et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Prefrontal and Striatal Glutamate Differently Relate to Striatal Dopamine: Potential Regulatory Mechanisms of Striatal Presynaptic Dopamine Function?
Tobias Gleich et al.
JOURNAL OF NEUROSCIENCE (2015)
Dopaminergic differentiation of schizophrenia hiPSCs
B. J. Hartley et al.
MOLECULAR PSYCHIATRY (2015)
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Y. Iwata et al.
MOLECULAR PSYCHIATRY (2015)
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
Andrew J. Pocklington et al.
NEURON (2015)
The dopaminergic response to acute stress in health and psychopathology: A systematic review
Thomas Vaessen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia
Samuel M. Cohen et al.
SCHIZOPHRENIA RESEARCH (2015)
Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
Amr Ellaithy et al.
TRENDS IN NEUROSCIENCES (2015)
Ventral Striatal Activation During Reward Processing in Psychosis A Neurofunctional Meta-Analysis
Joaquim Radua et al.
JAMA PSYCHIATRY (2015)
Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia A Positron Emission Tomographic Functional Magnetic Resonance Imaging Study
Mark Slifstein et al.
JAMA PSYCHIATRY (2015)
No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder
D. Hernaus et al.
TRANSLATIONAL PSYCHIATRY (2015)
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Wei Hu et al.
YEAR IN NEUROLOGY AND PSYCHIATRY (2015)
Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia
K. Brennand et al.
MOLECULAR PSYCHIATRY (2015)
Salience processing and insular cortical function and dysfunction
Lucina Q. Uddin
NATURE REVIEWS NEUROSCIENCE (2015)
Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task
Reggie Taylor et al.
NPJ SCHIZOPHRENIA (2015)
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Arsime Demjaha et al.
BIOLOGICAL PSYCHIATRY (2014)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael A. P. Bloomfield et al.
BIOLOGICAL PSYCHIATRY (2014)
Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies
Joseph Kambeitz et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Linking Microcircuit Dysfunction to Cognitive Impairment: Effects of Disinhibition Associated with Schizophrenia in a Cortical Working Memory Model
John D. Murray et al.
CEREBRAL CORTEX (2014)
Neuropathological changes in the substantia nigra in schizophrenia but not depression
M. R. Williams et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E. M. P. Poels et al.
MOLECULAR PSYCHIATRY (2014)
Synaptic dysregulation in a human iPS cell model of mental disorders
Zhexing Wen et al.
NATURE (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Sparse, decorrelated odor coding in the mushroom body enhances learned odor discrimination
Andrew C. Lin et al.
NATURE NEUROSCIENCE (2014)
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
Mehdi Farokhnia et al.
PSYCHOPHARMACOLOGY (2014)
Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users
James M. Stone et al.
PSYCHOPHARMACOLOGY (2014)
Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models
Sungkun Chun et al.
SCIENCE (2014)
Bitopertin The Good News and Bad News
Donald C. Goff
JAMA PSYCHIATRY (2014)
GABA and glutamate in schizophrenia: A 7 T H-1-MRS study
Anouk Marsman et al.
NEUROIMAGE-CLINICAL (2014)
Human iPSC Neurons Display Activity-Dependent Neurotransmitter Secretion: Aberrant Catecholamine Levels in Schizophrenia Neurons
Vivian Hook et al.
STEM CELL REPORTS (2014)
Modeling Hippocampal Neurogenesis Using Human Pluripotent Stem Cells
Diana Xuan Yu et al.
STEM CELL REPORTS (2014)
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Alice Egerton et al.
BIOLOGICAL PSYCHIATRY (2013)
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
Oliver D. Howes et al.
BRAIN (2013)
Effects of Age and Sex on the Concentrations of Glutamate and Glutamine in the Human Brain
Sven Haedel et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients
O. Robicsek et al.
MOLECULAR PSYCHIATRY (2013)
Cortical connectivity and sensory coding
Kenneth D. Harris et al.
NATURE (2013)
NMDA Receptors Subserve Persistent Neuronal Firing during Working Memory in Dorsolateral Prefrontal Cortex
Min Wang et al.
NEURON (2013)
Neural Primacy of the Salience Processing System in Schizophrenia
Lena Palaniyappan et al.
NEURON (2013)
Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
Scott A. Schobel et al.
NEURON (2013)
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
Romina Mizrahi et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction
Darrick T. Balu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
In vivo binding of the dopamine-1 receptor PET tracers [11C]NNC112 and [11C]SCH23390: a comparison study in individuals with schizophrenia
Eline M. P. Poels et al.
PSYCHOPHARMACOLOGY (2013)
Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2013)
Support for the N-Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia From Exome Sequencing in Multiplex Families
Andrew E. Timms et al.
JAMA PSYCHIATRY (2013)
Decline in Cognitive Performance Between Ages 13 and 18 Years and the Risk for Psychosis in Adulthood A Swedish Longitudinal Cohort Study in Males
James H. MacCabe et al.
JAMA PSYCHIATRY (2013)
Connectivity, Pharmacology, and Computation: Toward a Mechanistic Understanding of Neural System Dysfunction in Schizophrenia
Alan Anticevic et al.
Frontiers in Psychiatry (2013)
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
Kate Merritt et al.
Frontiers in Psychiatry (2013)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Negative Symptoms and the Failure to Represent the Expected Reward Value of Actions
James M. Gold et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Increased Stress-Induced Dopamine Release in Psychosis
Romina Mizrahi et al.
BIOLOGICAL PSYCHIATRY (2012)
A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Increased prefrontal cortical D1 receptors in drug naive patients with schizophrenia: a PET study with [11C]NNC112
Anissa Abi-Dargham et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Magnetic resonance imaging of glutamate
Kejia Cai et al.
NATURE MEDICINE (2012)
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Maurizio Popoli et al.
NATURE REVIEWS NEUROSCIENCE (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex
Mahomi Kuroiwa et al.
PSYCHOPHARMACOLOGY (2012)
Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging
Nina B. L. Urban et al.
PSYCHOPHARMACOLOGY (2012)
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
David A. Lewis et al.
TRENDS IN NEUROSCIENCES (2012)
Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
Thomas L. Schwartz et al.
FRONTIERS IN PHARMACOLOGY (2012)
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Deficits in Positive Reinforcement Learning and Uncertainty-Driven Exploration Are Associated with Distinct Aspects of Negative Symptoms in Schizophrenia
Gregory P. Strauss et al.
BIOLOGICAL PSYCHIATRY (2011)
Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
Surendra P. Singh et al.
CNS DRUGS (2011)
Modelling schizophrenia using human induced pluripotent stem cells
Kristen J. Brennand et al.
NATURE (2011)
From reinforcement learning models to psychiatric and neurological disorders
Tiago V. Maia et al.
NATURE NEUROSCIENCE (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia
Gregory C. Carlson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Striatal dopamine synthesis capacity in twins discordant for schizophrenia
P. Shotbolt et al.
PSYCHOLOGICAL MEDICINE (2011)
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Altered Relationship Between Hippocampal Glutamate Levels and Striatal Dopamine Function in Subjects at Ultra High Risk of Psychosis
James M. Stone et al.
BIOLOGICAL PSYCHIATRY (2010)
Saliency, switching, attention and control: a network model of insula function
Vinod Menon et al.
BRAIN STRUCTURE & FUNCTION (2010)
Proton MRS in twin pairs discordant for schizophrenia
E. S. Lutkenhoff et al.
MOLECULAR PSYCHIATRY (2010)
Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia
Jun Kosaka et al.
LIFE SCIENCES (2010)
Abnormal neural oscillations and synchrony in schizophrenia
Peter J. Uhlhaas et al.
NATURE REVIEWS NEUROSCIENCE (2010)
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
Alice Egerton et al.
NEUROIMAGE (2010)
Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
Ningning Guo et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress
Jerome Brunelin et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2010)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naive Schizophrenic Subjects
Anissa Abi-Dargham et al.
BIOLOGICAL PSYCHIATRY (2009)
Why do delusions persist?
Philip R. Corlett et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2009)
Increase in thalamic binding of [11C]PE2I in patients with schizophrenia: A positron emission tomography study of dopamine transporter
Ryosuke Arakawa et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice
Viviane Labrie et al.
LEARNING & MEMORY (2009)
Two types of dopamine neuron distinctly convey positive and negative motivational signals
Masayuki Matsumoto et al.
NATURE (2009)
The dopaminergic basis of human behaviors: A review of molecular imaging studies
Alice Egerton et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Yoshitaka Kumakura et al.
NEUROSCIENTIST (2009)
The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis
Jari Tiihonen et al.
SCHIZOPHRENIA RESEARCH (2009)
Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
Shin'Ya Tayoshi et al.
SCHIZOPHRENIA RESEARCH (2009)
New Effect Size Rules of Thumb
Shlomo S. Sawilowsky
JOURNAL OF MODERN APPLIED STATISTICAL METHODS (2009)
Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia
K. J. Lee et al.
ACTA PSYCHIATRICA SCANDINAVICA (2008)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia
Jukka Huttunen et al.
BIOLOGICAL PSYCHIATRY (2008)
The glutamate-glutamine cycle is not stoichiometric: Fates of glutamate in brain
Mary C. McKenna
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
The amphetamine-induced sensitized state as a model of schizophrenia
R. E. Featherstone et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia:: An [18F]fluorodopa/positron emission tomography study
Yoshitaka Kumakura et al.
JOURNAL OF NEUROSCIENCE (2007)
How should DSM-V criteria for schizophrenia include cognitive impairment?
Richard S. E. Keefe et al.
SCHIZOPHRENIA BULLETIN (2007)
In vivo DA D1 receptor selectivity of NNC 112 and SCH 23390
Jesper Ekelund et al.
MOLECULAR IMAGING AND BIOLOGY (2007)
Breakthrough dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time
Anne-Noel Samaha et al.
JOURNAL OF NEUROSCIENCE (2007)
Measurements of the anaplerotic rate in the human cerebral cortex using C-13 magnetic resonance spectroscopy and [1-C-13] and [2-C-13] glucose
Graeme F. Mason et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia
John H. Krystal et al.
NEUROTOXICITY RESEARCH (2006)
The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer
Lasse K. Bak et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Glutamate and schizophrenia: Beyond the dopamine hypothesis
Joseph T. Coyle
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning
C Kellendonk et al.
NEURON (2006)
Super-resolution in PET imaging
JA Kennedy et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2006)
Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia
J Hirvonen et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
Increased prefrontal and hippocampal glutamate concentration in schizophrenia:: Evidence from a magnetic resonance spectroscopy study
LT van Elst et al.
BIOLOGICAL PSYCHIATRY (2005)
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
JH Krystal et al.
PSYCHOPHARMACOLOGY (2005)
Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care:: a positron emission tomography study using [11C]raclopride
JC Pruessner et al.
JOURNAL OF NEUROSCIENCE (2004)
Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia
HT Mueller et al.
MOLECULAR BRAIN RESEARCH (2004)
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide
A Abi-Dargham et al.
BIOLOGICAL PSYCHIATRY (2004)
Dopamine depletion and in vivo binding of PET D1 receptor radioligands:: Implications for imaging studies in schizophrenia
NN Guo et al.
NEUROPSYCHOPHARMACOLOGY (2003)
In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine:: Differential findings with [3H]raclopride versus [3H]spiperone
W Sun et al.
MOLECULAR PHARMACOLOGY (2003)
Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia
S Kapur
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Increased platelet vesicular monoamine transporter density in adult schizophrenia patients
M Zucker et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2002)
PET study of D1 dopamine receptor binding in neuroleptic-naive patients with schizophrenia
P Karlsson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Prefrontal dopamine D1 receptors and working memory in schizophrenia
A Abi-Dargham et al.
JOURNAL OF NEUROSCIENCE (2002)
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
DC Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects
JK Zubieta et al.
BIOLOGICAL PSYCHIATRY (2001)
Aging alters regional multichemical profile of the human brain: an in vivo H-1-MRS study of young versus middle-aged subjects
ID Grachev et al.
JOURNAL OF NEUROCHEMISTRY (2001)
In vivo measurement of the vesicular monoamine transporter in schizophrenia
SF Taylor et al.
NEUROPSYCHOPHARMACOLOGY (2000)
6-18F-DOPA PET study in patients with schizophrenia
AM Elkashef et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2000)
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans:: a clinical PET study
S Silvestri et al.
PSYCHOPHARMACOLOGY (2000)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
分享论文
